Tapewire

Nasdaq · USD

LIVN

LivaNova PLC

Export transactions ↓
Tapewire entity
507
SEC CIK
0001639691
Parsed reports
465

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionPerformance Stock Units · Derivative 5,768 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 7

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

F9 · derivative.exercise_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired.

F9 · derivative.expiration_date: On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 3,621 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 6

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,240

Underlying: Ordinary Shares · 3,621 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

F7 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement.

F7 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,787 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 5

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,575

Underlying: Ordinary Shares · 1,787 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

F6 · derivative.exercise_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

F6 · derivative.expiration_date: On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,364 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 4

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,364

Underlying: Ordinary Shares · 2,364 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

F5 · derivative.exercise_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

F5 · derivative.expiration_date: On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 914 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · derivative · entry 3

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 914 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

F4 · derivative.exercise_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

F4 · derivative.expiration_date: On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Tax withholdingOrdinary Shares 12,868 $61.27 $788,422.36
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · nonDerivative · entry 2

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,647

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:20 UTC
Shvartsburg AlexChief Financial Officer
Exercise / conversionOrdinary Shares 30,835 $0.00 $0.00
Disclosure

SEC source: 0001639691-26-000025 · wk-form4_1775078415.xml · nonDerivative · entry 1

Shvartsburg Alex · CIK 0001830830 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,515

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 17:25 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionStock Appreciation Rights · Derivative 2,140 $0.00 Strike: $57.60 $0.00
Disclosure

SEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · derivative · entry 5

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,140 shares

Expires 2026-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 17:25 UTC
Poletti FrancoPresident, Cardiopulmonary
Tax withholdingOrdinary Shares 69 $62.26 $4,295.94
Disclosure

SEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 3

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,941

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 17:25 UTC
Poletti FrancoPresident, Cardiopulmonary
Tax withholdingOrdinary Shares 1,980 $62.26 $123,274.80
Disclosure

SEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 2

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,010

F1 · shares: Shares withheld for stock appreciation right ("SAR") base price settlement.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 17:25 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionOrdinary Shares 2,140 $57.60 $123,264.00
Disclosure

SEC source: 0001639691-26-000015 · wk-form4_1773437128.xml · nonDerivative · entry 1

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,990

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionRestricted Stock Units · Derivative 967 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · derivative · entry 4

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 967 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Poletti FrancoPresident, Cardiopulmonary
Tax withholdingOrdinary Shares 416 $63.06 $26,232.96
Disclosure

SEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · nonDerivative · entry 2

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,850

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionOrdinary Shares 967 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000163 · wk-form4_1766005586.xml · nonDerivative · entry 1

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,355 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · derivative · entry 3

PODLOGAR SUSAN M · CIK 0001709959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,355 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:06 UTC Tax withholdingOrdinary Shares 269 $63.06 $16,963.14
Disclosure

SEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 2

PODLOGAR SUSAN M · CIK 0001709959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,086

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:06 UTC Exercise / conversionOrdinary Shares 2,355 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 1

PODLOGAR SUSAN M · CIK 0001709959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Hutchinson Michael DamonSVP, CLO and Company Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · derivative · entry 3

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,253

Underlying: Ordinary Shares · 2,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On December 15, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the third vesting for which occurred on December 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Hutchinson Michael DamonSVP, CLO and Company Secretary
Tax withholdingOrdinary Shares 1,122 $63.06 $70,753.32
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 2

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,798

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:06 UTC
Hutchinson Michael DamonSVP, CLO and Company Secretary
Exercise / conversionOrdinary Shares 2,254 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000161 · wk-form4_1766005572.xml · nonDerivative · entry 1

Hutchinson Michael Damon · CIK 0001606626 · SVP, CLO and Company Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 20:57 UTC
Story BrookeDirector
SaleOrdinary Shares 250 $53.94 $13,485.00
Disclosure

SEC source: 0001639691-25-000154 · wk-form4_1763585818.xml · nonDerivative · entry 1

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,232

Read SEC document
September 15, 2025 Filed Sep 17, 2025 16:05 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionRestricted Stock Units · Derivative 643 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · derivative · entry 4

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932

Underlying: Ordinary Shares · 643 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement.

F4 · derivative.exercise_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 16:05 UTC
Poletti FrancoPresident, Cardiopulmonary
Tax withholdingOrdinary Shares 277 $55.43 $15,354.11
Disclosure

SEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · nonDerivative · entry 2

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,299

F2 · shares: Shares withheld to satisfy tax liability.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 16:05 UTC
Poletti FrancoPresident, Cardiopulmonary
Exercise / conversionOrdinary Shares 643 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000135 · wk-form4_1758139532.xml · nonDerivative · entry 1

Poletti Franco · CIK 0002031281 · President, Cardiopulmonary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 20:08 UTC GrantRestricted Stock Units · Derivative 2,560 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000137 · wk-form4_1758139698.xml · derivative · entry 1

Zurbay Donald · CIK 0001341608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,560

Underlying: Ordinary Shares · 2,560 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2025 Director Incentive Award Plan (the "Plan") and the award agreement.

F2 · derivative.exercise_date: On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement.

F2 · derivative.expiration_date: On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:17 UTC SaleOrdinary Shares 1,500 $56.50 $84,750.00
Disclosure

SEC source: 0001639691-25-000110 · wk-form4_1756325830.xml · nonDerivative · entry 1

Bianchi Francesco · CIK 0001656080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,028

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:53 UTC
Tezel AhmetChief Innovation Officer
Exercise / conversionRestricted Stock Units · Derivative 2,967 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · derivative · entry 3

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,896

Underlying: Ordinary Shares · 2,967 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:53 UTC
Tezel AhmetChief Innovation Officer
Tax withholdingOrdinary Shares 1,032 $45.76 $47,224.32
Disclosure

SEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 2

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,935

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:53 UTC
Tezel AhmetChief Innovation Officer
Exercise / conversionOrdinary Shares 2,967 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 1

Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC
Story BrookeDirector
GrantRestricted Stock Units · Derivative 4,042 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 4

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Ordinary Shares · 4,042 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC
Story BrookeDirector
Exercise / conversionRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · derivative · entry 3

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC
Story BrookeDirector
Tax withholdingOrdinary Shares 410 $45.76 $18,761.60
Disclosure

SEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 2

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,482

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC
Story BrookeDirector
Exercise / conversionOrdinary Shares 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000079 · wk-form4_1750193653.xml · nonDerivative · entry 1

Story Brooke · CIK 0001866136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC GrantRestricted Stock Units · Derivative 4,042 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 4

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Ordinary Shares · 4,042 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · derivative · entry 3

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Tax withholdingOrdinary Shares 410 $45.76 $18,761.60
Disclosure

SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 2

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,362

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionOrdinary Shares 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000080 · wk-form4_1750193664.xml · nonDerivative · entry 1

Barry James Christopher · CIK 0001756949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:53 UTC GrantRestricted Stock Units · Derivative 4,042 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000075 · wk-form4_1750193614.xml · derivative · entry 1

PODLOGAR SUSAN M · CIK 0001709959 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Ordinary Shares · 4,042 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F2 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F2 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC GrantRestricted Stock Units · Derivative 4,042 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · derivative · entry 4

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Ordinary Shares · 4,042 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · derivative · entry 3

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Tax withholdingOrdinary Shares 410 $45.76 $18,761.60
Disclosure

SEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · nonDerivative · entry 2

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,738

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionOrdinary Shares 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000077 · wk-form4_1750193633.xml · nonDerivative · entry 1

WILVER PETER M · CIK 0001234537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC GrantRestricted Stock Units · Derivative 5,681 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · derivative · entry 4

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,681

Underlying: Ordinary Shares · 5,681 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionRestricted Stock Units · Derivative 4,840 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · derivative · entry 3

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 4,840 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Tax withholdingOrdinary Shares 581 $45.76 $26,586.56
Disclosure

SEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · nonDerivative · entry 2

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,567

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionOrdinary Shares 4,840 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000081 · wk-form4_1750193673.xml · nonDerivative · entry 1

KOZY WILLIAM A · CIK 0001221785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC GrantRestricted Stock Units · Derivative 4,042 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · derivative · entry 4

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,042

Underlying: Ordinary Shares · 4,042 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.

F6 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

F6 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionRestricted Stock Units · Derivative 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · derivative · entry 3

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,416 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

F4 · derivative.exercise_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

F4 · derivative.expiration_date: RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Tax withholdingOrdinary Shares 410 $45.76 $18,761.60
Disclosure

SEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · nonDerivative · entry 2

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,063

F3 · shares: Shares withheld to satisfy tax liability.

Read SEC document
June 15, 2025 Filed Jun 17, 2025 20:54 UTC Exercise / conversionOrdinary Shares 3,416 $0.00 $0.00
Disclosure

SEC source: 0001639691-25-000082 · wk-form4_1750193683.xml · nonDerivative · entry 1

SCHERMERHORN TODD C · CIK 0001204654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.

F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.